Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
491
Bearish filings
9
Named actors
9
Disclosed $ (bull / bear)
$932.0M / $5.5M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-23 | Director Yang Taiyin | exercised options & held the shares | $47K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $187K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $185K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $684K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $9K | SEC ↗ |
475+ more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only — a dense name; figures cover the most recent 500. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $274K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $464K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $150K | SEC ↗ |
| 2026-10-21 | Chief Financial Officer BORGESON JOHN A. | sold | $746K | SEC ↗ |
| 2026-10-21 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOHN BORGESON | filed notice to sell | $2.8M | SEC ↗ |
| 2026-09-29 | Director BAKER BROS. ADVISORS LP | bought | $7K | SEC ↗ |
| 2026-09-29 | Director BAKER FELIX | bought | $7K | SEC ↗ |
| 2026-09-29 | Director Baker Brothers Life Sciences LP | bought | $875K | SEC ↗ |
| 2026-09-29 | Director 667, L.P. | bought | $875K | SEC ↗ |
| 2026-09-29 | Director BAKER JULIAN | bought | $7K | SEC ↗ |
| 2026-09-29 | Director BAKER BROS. ADVISORS LP | bought | $122K | SEC ↗ |
| 2026-09-29 | Director BAKER JULIAN | bought | $875K | SEC ↗ |
| 2026-09-29 | Director BAKER JULIAN | bought | $52K | SEC ↗ |
| 2026-09-29 | Director BAKER FELIX | bought | $122K | SEC ↗ |
| 2026-09-29 | Director BAKER FELIX | bought | $1.7M | SEC ↗ |
| 2026-09-29 | Director BAKER FELIX | bought | $102K | SEC ↗ |
| 2026-09-29 | Director BAKER FELIX | bought | $875K | SEC ↗ |
| 2026-09-29 | Director Baker Brothers Life Sciences LP | bought | $122K | SEC ↗ |
| 2026-09-29 | Director Baker Brothers Life Sciences LP | bought | $7K | SEC ↗ |
| 2026-09-29 | Director Baker Brothers Life Sciences LP | bought | $1.7M | SEC ↗ |